LM
Litton Mark James
Chairman & CEO
C-suiteM
Insider track record
CEONot enough buy signals with a settled T+90 horizon to measure a track record yet.
Browse the complete record of transactions filed by Litton Mark James, Chairman & CEO. Insider active across 3 companies, notably Athira Pharma, Inc.. In total, 14 disclosures have been logged. Breakdown: 0 buy · 2 sells. History available since 18 May 2021. The latest transaction was filed on 3 March 2026 (Levée d'options). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Litton Mark James
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations14 total
22,254 shares0Common StockSEC:0001604834-26-000006:0
10,834 shares0Common StockSEC:0001604834-26-000002:0
108,334 shares0Common StockSEC:0001415889-25-019069:0
108,333 shares0Common StockSEC:0001415889-25-000536:0
20,000 shares0Common StockSEC:0001415889-24-022983:0
20,000 shares0Common StockSEC:0001415889-24-004153:0
20,000 shares0Common StockSEC:0001209191-24-001150:0
662 shares@ US$2.743.7% of flowCommon StockSEC:0001209191-23-005818:0
757 shares@ US$7.0611.3% of flowCommon StockSEC:0001209191-22-039340:0
885 shares@ US$12.5136.4% of flowCommon StockSEC:0001209191-22-005628:0
867 shares@ US$14.4538.1% of flowCommon StockSEC:0001209191-21-052564:0
25,000 sharesCommon StockSEC:0001209191-16-090205:0
17,291 sharesCommon StockSEC:0001209191-16-090205:1
7,709 sharesCommon StockSEC:0001209191-16-090205:2
About Litton Mark James
Litton Mark James is President and CEO. He has 14 filings in total, and in the 14 sampled filings the transactions are Attribution, with a date range from 2016-01-06 to 2026-03-05, purchase volume of EUR 0 and sale volume of EUR 0.